Virginia L. Stauffer

Evaluation of Galcanezumab for the Prevention of Episodic Migraine

Virginia L. Stauffer, David W. Dodick, Qi Zhang et al. · JAMA Neurology · 2018 · 547 citations · Full text

Early Response to Antipsychotic Drug Therapy as a Clinical Marker of Subsequent Response in the Treatment of Schizophrenia

Bruce J. Kinon, Lei Chen, Haya Ascher‐Svanum et al. · Neuropsychopharmacology · 2009 · 175 citations · Full text

Subsequent Response, Antipsychotic Drug Therapy, Early Response +13

Predicting response to atypical antipsychotics based on early response in the treatment of schizophrenia☆

Bruce J. Kinon, Lichang Chen, Haya Ascher‐Svanum et al. · Schizophrenia Research · 2008 · 165 citations

Early Response, Psychiatry, Psychotic Disorder +11

Medication Nonadherence and Treatment Outcome in Patients With Schizophrenia or Schizoaffective Disorder With Suboptimal Prior Response

Jean-Pierre Lindenmayer, Hong Liu‐Seifert, Pandurang M. Kulkarni et al. · The Journal of Clinical Psychiatry · 2009 · 161 citations

A phase 3, long-term, open-label safety study of Galcanezumab in patients with migraine

Angelo Camporeale, David Kudrow, Ryan Sides et al. · BMC Neurology · 2018 · 140 citations · Full text